Astellas Pharma, Inc. (ALPMF)
13.35
0.00 (0.00%)
USD |
OTCM |
Jan 20, 16:00
Astellas Pharma Price: 13.35 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 16.10 |
| Nxera Pharma Co., Ltd. | 5.15 |
| PeptiDream Inc. | 10.75 |
| Stemcell Holdings, Inc. | 0.06 |
Price Related Metrics
| PE Ratio | 27.91 |
| PS Ratio | 1.779 |
| PEG Ratio | 0.1965 |
| Price to Book Value | 2.190 |
| Price to Free Cash Flow | 10.51 |
| Earnings Yield | 3.58% |
| Market Cap | 23.91B |
| PEGY Ratio | 0.1914 |
| Operating PE Ratio | 9.906 |
| Normalized PE Ratio | 27.91 |